台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    70.8
  • 漲跌
    ▲1.0
  • 漲幅
    +1.43%
  • 成交量
    89
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
訊聯 (1784)籌碼相關-華南永昌-民權 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/0605/306065707580859095Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

華南永昌-民權 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22082.2000.0083.1004370.00%
2024/12/0600.00198.1095.00-1560-0.18%
2024/12/042101.001103.50100.5015500.18%
2024/11/20192.10195.8095.9005650.00%
2024/10/2500.00194.7094.80-1927-0.11%
2024/10/241100.0000.0096.2019830.10%
2024/09/1000.003103.83103.00-32,475-0.12%
2024/09/0300.001115.00113.50-12,634-0.04%
2024/08/301118.5000.00116.5012,7630.04%
2024/08/291121.0000.00118.0012,8210.04%
2024/08/2700.002121.50122.00-22,958-0.07%
2024/08/265120.302120.50120.5032,9860.10%
2024/08/1200.001114.50112.00-12,962-0.03%
2024/08/071108.5000.00108.5012,9060.03%
2024/08/061103.001102.00103.0002,8900.00%
2024/07/311117.0000.00114.5012,7900.04%
2024/07/301112.501117.50116.5002,7790.00%
2024/07/2200.001147.50136.00-12,647-0.04%
2024/07/192169.5010167.20145.50-82,572-0.31%
2024/07/181159.506155.00161.50-52,302-0.22%
2024/07/172146.5000.00147.0022,2110.09%
2024/07/161142.0000.00141.5012,1980.05%
2024/07/111142.5000.00140.0012,1630.05%
2024/07/095144.9000.00143.5052,1300.23%
2024/07/041130.503130.67135.50-22,027-0.10%
2024/07/032136.0000.00133.0022,0080.10%
2024/07/028134.255134.50140.0031,9350.16%
2024/07/0100.001127.50139.50-11,729-0.06%
2024/06/283121.332127.00127.0011,6230.06%
2024/06/2000.00295.8599.40-21,308-0.15%
2024/06/19199.70197.0094.2001,2790.00%
2024/06/18197.3000.0096.1011,2420.08%
2024/06/17193.7000.0091.5011,1950.08%
2024/06/131086.971089.1885.3001,1250.00%
2024/06/0700.00186.5083.00-11,017-0.10%
2024/06/06181.0000.0081.2019690.10%
2024/06/052084.522084.2587.0009070.00%
博而美攜訊聯細胞智藥進軍醫美、牙科上萬家院所 擴大外泌體應用Anue鉅亨-30天前
訊聯攜手清冠一號團隊 打造中草藥外泌體新複方Anue鉅亨-2025/04/29
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯 相關文章
訊聯 相關影音